Xalkori 200 mg

XALKORI 200 MG capsules are a pharmaceutical product containing crizotinib, used for targeted therapy. This medication is designed to interact with specific proteins in the body, often utilized in cancer treatment protocols.

XALKORI 200 MG capsules are primarily used in the treatment of certain types of cancer. The active ingredient, crizotinib, targets specific proteins that may play a role in cancer cell growth. This medication is often prescribed for patients with specific genetic markers, as determined by a healthcare provider. XALKORI is used for what is known as targeted therapy, aiming to interfere with the growth and spread of cancer cells.

Common effects of XALKORI 200 MG capsules may include nausea, vomiting, and diarrhea. Some users may experience fatigue, vision changes, or swelling. It is important to monitor for any unusual symptoms and consult a healthcare provider if significant side effects occur. The effects can vary widely among individuals, depending on their specific health conditions and other factors.

XALKORI 200 MG capsules should be handled with care and stored as directed. It is crucial to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should discuss the use of XALKORI with their healthcare provider.

XALKORI 200 MG capsules may interact with certain medications, including those that are metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and other substances that affect liver function may also interact with XALKORI, so it is advisable to avoid them unless directed otherwise by a healthcare professional.